SOSV

InnSight Technology is a biotechnology company focused on advancing the diagnostics and evaluation of eye diseases. The company specializes in developing innovative ophthalmic devices, including a novel, hand-held biosensor designed for the detection of anterior ophthalmic injuries. Additionally, InnSight Technology works on the development of nanotechnology-based medical devices aimed at addressing various clinical needs in ophthalmology. By providing these advanced tools, the company enables clinicians to enhance ocular care and improve patient outcomes in eye health.

Kfobix is a technology company specializing in the development and application of advanced nanocomposite coatings for enhancing the durability and efficiency of energy infrastructure. The company's flagship product is a patented superhydrophobic coating, designed to prevent ice formation and water accumulation on surfaces such as wind turbine blades and power lines. This coating, applied via a simple spray method, offers high transparency, long-lasting durability, and ease of application, thereby reducing maintenance costs and operational disruptions in the energy sector. Additionally, Kfobix is pioneering anti-dirt coatings for solar panels, aiming to maximize their efficiency and output. The company's mission is to facilitate a seamless transition to renewable energy sources by addressing some of the most pressing challenges in the sector, ultimately promoting a cleaner, more reliable, and sustainable energy future.

Particella is a biotechnology company that specializes in developing a proprietary oral lipid nanoparticle technology designed to deliver mRNA and other nucleic acids. This innovative approach aims to transform the administration of biological medicines by utilizing the intestinal tract to facilitate the secretion of proteins into the bloodstream. By enabling the oral delivery of protein biologics, Particella's technology seeks to address the limitations of current methods, ultimately allowing healthcare providers to prevent gastrointestinal diseases in patients more effectively. The company's advancements hold the potential to create a new category of medicines, enhancing the accessibility and efficacy of treatments.

Synplexity is a biotechnology company located in New Castle, Delaware, specializing in mutational scanning and multiplexed gene synthesis through advanced artificial intelligence technology. The company operates a large-scale gene synthesis and proteomics discovery platform that utilizes microdroplets as microreactors. This innovative approach allows for the efficient creation of multiplex gene libraries, which have applications across various sectors, including therapeutics, biomanufacturing, agriculture, and climate systems. Synplexity aims to drive advancements in healthcare and other industries through its cutting-edge genetic technologies.

NanoPlume is a biomaterial manufacturer specializing in the large-scale production of innovative, eco-friendly biomaterials, notably Bio-Aerogel. The company focuses on creating advanced insulating biomaterials and aerogels, aiming to enhance energy and space efficiency, as well as promote circularity across various industries. By utilizing organic and recycled feedstocks and green technology, NanoPlume reduces waste and minimizes energy consumption. Its products are designed to insulate cargo boxes in the cold chain healthcare logistics sector, reducing payload and energy consumption, and extending battery range.

Minutia is a biotechnology company focused on developing innovative stem cell-derived transplants aimed at treating Type 1 Diabetes. The company specializes in creating insulin-producing cell transplants that incorporate proprietary nanosensors, allowing for real-time monitoring of transplant status. These immune-evasive cells are designed for subcutaneous implantation, addressing common challenges associated with transplant procedures. By advancing this technology, Minutia seeks to transform the clinical landscape for diabetes management and cell replacement therapies, ultimately working towards a functional cure for this condition.

Hidrogenics is a clean energy company specializing in methane pyrolysis technology. It converts methane into clean hydrogen and solid carbon products, such as synthetic graphite, carbon nanotubes, and graphene. The company's multi-metal catalyst-based process enables industries to decarbonize and transition towards green energy.

Level Zero Health is a technology company specializing in advanced biosensor solutions. It develops wearable devices equipped with DNA-based sensors, designed to precisely monitor key endocrine biomarkers in real-time. By combining biochemistry and nanotechnology, the company collects novel data, empowering users to gain insights into their hormonal health.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Founded in 2019, Karma Biotechnologies is a Los Angeles-based company dedicated to developing therapies for autoimmune diseases, allergies, and food sensitivities. It specializes in antigen-specific immunotherapies using lipid nanoparticle engineering.

Diadem Biotherapeutics is a biotechnology company dedicated to developing bio-therapeutical materials through organic methods. The company specializes in the creation of exosomes, which are cell-free vesicles engineered to signal through validated targets. Diadem's therapeutic platform aims to treat a variety of chronic inflammatory conditions, autoimmune diseases, and cancers. By focusing on the genetic engineering, manufacturing, and purification of these exosomes, Diadem provides innovative solutions for clinicians to effectively address immunopathologies and improve patient outcomes.

Particella is a biotechnology company that specializes in developing a proprietary oral lipid nanoparticle technology designed to deliver mRNA and other nucleic acids. This innovative approach aims to transform the administration of biological medicines by utilizing the intestinal tract to facilitate the secretion of proteins into the bloodstream. By enabling the oral delivery of protein biologics, Particella's technology seeks to address the limitations of current methods, ultimately allowing healthcare providers to prevent gastrointestinal diseases in patients more effectively. The company's advancements hold the potential to create a new category of medicines, enhancing the accessibility and efficacy of treatments.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative gene therapy treatments for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes advanced oral lipid nanoparticle technology to deliver mRNA and plasmid DNA directly to intestinal stem cells. This approach aims to address the root causes of gastrointestinal diseases, including Familial Adenomatous Polyposis (FAP), a hereditary condition that can lead to colorectal cancer and often necessitates invasive surgical interventions. DNALite's therapies seek to transform protein biologics into oral drugs, allowing for more effective and less invasive treatment options.

SepPure disrupts energy-intensive chemical separation processes like distillation. It uses novel nanofiltration membranes for sustainable separations, reducing global energy consumption, emissions, and pollution.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative gene therapy treatments for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes advanced oral lipid nanoparticle technology to deliver mRNA and plasmid DNA directly to intestinal stem cells. This approach aims to address the root causes of gastrointestinal diseases, including Familial Adenomatous Polyposis (FAP), a hereditary condition that can lead to colorectal cancer and often necessitates invasive surgical interventions. DNALite's therapies seek to transform protein biologics into oral drugs, allowing for more effective and less invasive treatment options.

Founded in 2020, SunGreenH2 specializes in developing high-performance electrolysers using nanotechnology and advanced materials. Headquartered in Singapore with offices in Melbourne and London, the company produces green hydrogen at low cost for industries, mobility, and energy storage.

SepPure disrupts energy-intensive chemical separation processes like distillation. It uses novel nanofiltration membranes for sustainable separations, reducing global energy consumption, emissions, and pollution.

Cellens is a medical device company based in Medford, Massachusetts, and is a spinoff from Tufts University, established in 2019. The company focuses on enhancing cancer detection through noninvasive screening methods. It has developed a cell surface scanning platform that utilizes atomic force microscopy imaging and machine learning to assist oncologists in the detection of bladder cancer. By analyzing physio-biomarkers on cell surfaces derived from urine samples, Cellens provides a diagnostic score that helps healthcare professionals minimize the need for invasive and costly procedures, thereby improving patient outcomes in bladder cancer diagnostics.

Cellens is a medical device company based in Medford, Massachusetts, and is a spinoff from Tufts University, established in 2019. The company focuses on enhancing cancer detection through noninvasive screening methods. It has developed a cell surface scanning platform that utilizes atomic force microscopy imaging and machine learning to assist oncologists in the detection of bladder cancer. By analyzing physio-biomarkers on cell surfaces derived from urine samples, Cellens provides a diagnostic score that helps healthcare professionals minimize the need for invasive and costly procedures, thereby improving patient outcomes in bladder cancer diagnostics.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Founded in 2019, Karma Biotechnologies is a Los Angeles-based company dedicated to developing therapies for autoimmune diseases, allergies, and food sensitivities. It specializes in antigen-specific immunotherapies using lipid nanoparticle engineering.

Founded in 2020, Advanced Microbubbles specializes in developing microbubble technology for targeted drug delivery. Utilizing ultrasound, the company's products temporarily open barriers like the blood-brain barrier to facilitate local drug entry, enhancing precision and reducing side effects.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Diadem Biotherapeutics is a biotechnology company dedicated to developing bio-therapeutical materials through organic methods. The company specializes in the creation of exosomes, which are cell-free vesicles engineered to signal through validated targets. Diadem's therapeutic platform aims to treat a variety of chronic inflammatory conditions, autoimmune diseases, and cancers. By focusing on the genetic engineering, manufacturing, and purification of these exosomes, Diadem provides innovative solutions for clinicians to effectively address immunopathologies and improve patient outcomes.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative gene therapy treatments for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes advanced oral lipid nanoparticle technology to deliver mRNA and plasmid DNA directly to intestinal stem cells. This approach aims to address the root causes of gastrointestinal diseases, including Familial Adenomatous Polyposis (FAP), a hereditary condition that can lead to colorectal cancer and often necessitates invasive surgical interventions. DNALite's therapies seek to transform protein biologics into oral drugs, allowing for more effective and less invasive treatment options.

Founded in 2020, SunGreenH2 specializes in developing high-performance electrolysers using nanotechnology and advanced materials. Headquartered in Singapore with offices in Melbourne and London, the company produces green hydrogen at low cost for industries, mobility, and energy storage.

Kraken Sense develops an automated pathogen detection platform that uses cutting-edge nanotechnology and IoT-enabled dashboard for real-time bacterial contamination monitoring.

BioFeyn develops aquafeed ingredients that enhance the nutrition and sustainability of farmed fish. By optimizing marine ingredients and applying biodegradable nanoencapsulation, the company improves digestion, absorption, and bioavailability of nutrients, enabling delivery to specific tissues. This targeted delivery supports healthier growth and disease prevention in fish while reducing environmental pollution. The approach combines modular nutrient delivery with natural disease preventatives, helping clients produce farmed fish that are both nutritious and more sustainable.

Bucha Bio creates a novel biomaterial grown from infinitely renewable bacterial-nanocellulose. Strands of natural fibers interlock to form a high-performance textile with a luxuriously soft handfeel. Produced in weeks rather than months or years, use it in premium applications instead of animal leather, polyurethane, latex, vinyl, and so much more. Creating a reliable material is our goal, adding plastics and petrochemicals like PU polyurethane would make it easy, but we’ve never taken the easy way out. Committed to sustainability, Bucha Bio’s team is dedicated to creating a completely biodegradable textile that enables the next generation of designers to create products for a more sustainable future. Our biomaterial is water-resistant, scratch-resistant, sunlight-resistant, flame-resistant, and so many more reasons to test it out in your next product.

BioFeyn develops aquafeed ingredients that enhance the nutrition and sustainability of farmed fish. By optimizing marine ingredients and applying biodegradable nanoencapsulation, the company improves digestion, absorption, and bioavailability of nutrients, enabling delivery to specific tissues. This targeted delivery supports healthier growth and disease prevention in fish while reducing environmental pollution. The approach combines modular nutrient delivery with natural disease preventatives, helping clients produce farmed fish that are both nutritious and more sustainable.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Founded in 2020, Advanced Microbubbles specializes in developing microbubble technology for targeted drug delivery. Utilizing ultrasound, the company's products temporarily open barriers like the blood-brain barrier to facilitate local drug entry, enhancing precision and reducing side effects.

Founded in 2020, Advanced Microbubbles specializes in developing microbubble technology for targeted drug delivery. Utilizing ultrasound, the company's products temporarily open barriers like the blood-brain barrier to facilitate local drug entry, enhancing precision and reducing side effects.

Founded in 2019, Karma Biotechnologies is a Los Angeles-based company dedicated to developing therapies for autoimmune diseases, allergies, and food sensitivities. It specializes in antigen-specific immunotherapies using lipid nanoparticle engineering.

SepPure disrupts energy-intensive chemical separation processes like distillation. It uses novel nanofiltration membranes for sustainable separations, reducing global energy consumption, emissions, and pollution.

Diadem Biotherapeutics is a biotechnology company dedicated to developing bio-therapeutical materials through organic methods. The company specializes in the creation of exosomes, which are cell-free vesicles engineered to signal through validated targets. Diadem's therapeutic platform aims to treat a variety of chronic inflammatory conditions, autoimmune diseases, and cancers. By focusing on the genetic engineering, manufacturing, and purification of these exosomes, Diadem provides innovative solutions for clinicians to effectively address immunopathologies and improve patient outcomes.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative gene therapy treatments for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes advanced oral lipid nanoparticle technology to deliver mRNA and plasmid DNA directly to intestinal stem cells. This approach aims to address the root causes of gastrointestinal diseases, including Familial Adenomatous Polyposis (FAP), a hereditary condition that can lead to colorectal cancer and often necessitates invasive surgical interventions. DNALite's therapies seek to transform protein biologics into oral drugs, allowing for more effective and less invasive treatment options.

SepPure disrupts energy-intensive chemical separation processes like distillation. It uses novel nanofiltration membranes for sustainable separations, reducing global energy consumption, emissions, and pollution.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative gene therapy treatments for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes advanced oral lipid nanoparticle technology to deliver mRNA and plasmid DNA directly to intestinal stem cells. This approach aims to address the root causes of gastrointestinal diseases, including Familial Adenomatous Polyposis (FAP), a hereditary condition that can lead to colorectal cancer and often necessitates invasive surgical interventions. DNALite's therapies seek to transform protein biologics into oral drugs, allowing for more effective and less invasive treatment options.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative gene therapy treatments for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes advanced oral lipid nanoparticle technology to deliver mRNA and plasmid DNA directly to intestinal stem cells. This approach aims to address the root causes of gastrointestinal diseases, including Familial Adenomatous Polyposis (FAP), a hereditary condition that can lead to colorectal cancer and often necessitates invasive surgical interventions. DNALite's therapies seek to transform protein biologics into oral drugs, allowing for more effective and less invasive treatment options.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

ViaeX Technologies Inc. specializes in the development and manufacturing of bio-engineered nano-membrane technology solutions aimed at purifying water and air. The company's innovative biological nanofiltration systems are designed to be 400% more efficient than conventional methods, targeting specific pollutants and bacteria. These systems are biodegradable, cost-effective, and easily scalable, making them suitable for rapid deployment in cities facing significant pollution challenges. ViaeX's focus is on creating energy-efficient and environmentally friendly filtration systems that cater to industrial and municipal needs. The company's technological advancements are grounded in extensive research conducted at UC Berkeley and UC San Diego, utilizing breakthroughs in physical chemistry and nanotechnology. Additionally, ViaeX is developing sustainable nanomaterials from bio-waste, which can be applied across various industries, including water purification and food filtration, thereby reducing dependency on traditional materials and contributing to a more sustainable future.

Vali Nanomedical Corporation is a biotechnology company established in 2013 and headquartered in Los Angeles, California. The company specializes in developing a multidrug-delivery platform that utilizes proprietary nanoparticles with unique multilayered structures. This innovative technology enables a single nanoparticle to transport multiple drugs to tumors simultaneously, facilitating advanced cancer combination therapies that were previously unattainable. Vali's approach aims to enhance the specificity, efficacy, and safety of cancer treatments, offering healthcare providers new opportunities in the fight against cancer.

ViaeX Technologies Inc. specializes in the development and manufacturing of bio-engineered nano-membrane technology solutions aimed at purifying water and air. The company's innovative biological nanofiltration systems are designed to be 400% more efficient than conventional methods, targeting specific pollutants and bacteria. These systems are biodegradable, cost-effective, and easily scalable, making them suitable for rapid deployment in cities facing significant pollution challenges. ViaeX's focus is on creating energy-efficient and environmentally friendly filtration systems that cater to industrial and municipal needs. The company's technological advancements are grounded in extensive research conducted at UC Berkeley and UC San Diego, utilizing breakthroughs in physical chemistry and nanotechnology. Additionally, ViaeX is developing sustainable nanomaterials from bio-waste, which can be applied across various industries, including water purification and food filtration, thereby reducing dependency on traditional materials and contributing to a more sustainable future.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Vali Nanomedical Corporation is a biotechnology company established in 2013 and headquartered in Los Angeles, California. The company specializes in developing a multidrug-delivery platform that utilizes proprietary nanoparticles with unique multilayered structures. This innovative technology enables a single nanoparticle to transport multiple drugs to tumors simultaneously, facilitating advanced cancer combination therapies that were previously unattainable. Vali's approach aims to enhance the specificity, efficacy, and safety of cancer treatments, offering healthcare providers new opportunities in the fight against cancer.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

Founded in 2011, Verdex Technologies specializes in the mass production of non-toxic nanofibers using proprietary green technology. The company designs, patents, and licenses equipment for filtration and biomedical purposes, creating advanced performance nanofiber materials for various applications such as engine filters, liquid filters, industrial air filters, waterproof textiles, medical packaging, and face masks.

SouthWest NanoTechnologies, founded in 2001, specializes in the synthesis and commercialization of carbon nanotubes, particularly single-wall carbon nanotubes, using its proprietary CoMoCAT® technology developed by Professor Daniel Resasco. The company has established itself as a leading supplier of high-purity carbon nanotubes, catering to over 1,000 materials developers across diverse industries such as consumer electronics, energy storage, and composite manufacturing. Utilizing fluidized bed reactors, SouthWest NanoTechnologies employs a catalytic method that allows for precise control over the diameter, chirality, and purity of the nanotubes produced. This unique capability ensures that its carbon nanotubes possess exceptional thermal and chemical stability, making them suitable for a wide range of applications, including electronics, health care, and advanced composite materials.